Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.

@article{Brust2006FluorodeoxyglucoseII,
  title={Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation.},
  author={Douglas G Brust and Michael F. Polis and Richard T. Davey and Barbara Hahn and Stephen L. Bacharach and Millie Whatley and Anthony S. Fauci and Jorge A. Carrasquillo},
  journal={AIDS},
  year={2006},
  volume={20 4},
  pages={495-503}
}
OBJECTIVES Nodal uptake in areas of lymphocyte activation can be visualized using fluorodeoxyglucose (FDG). Various patterns of FDG accumulation in HIV-positive subjects have been described previously and hypothesized to potentially represent regions of active HIV replication and or nodal activation. We evaluated the utility of FDG scanning as a tool to study HIV pathogenesis. DESIGN We evaluated FDG biodistribution visually and quantitatively in HIV-negative individuals and various groups of… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

Differentiation of HIV-associated lymphoma from HIV-associated reactive adenopathy using quantitative FDG PET and symmetry

European Journal of Nuclear Medicine and Molecular Imaging • 2013
View 5 Excerpts
Highly Influenced

FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables

European Journal of Nuclear Medicine and Molecular Imaging • 2008
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…